Literature DB >> 15917569

Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime.

Samer A Alyaseen1, Kerryl E Piper, Mark S Rouse, James M Steckelberg, Robin Patel.   

Abstract

Exposure of ciprofloxacin- and cefepime-susceptible Pseudomonas aeruginosa isolates to increasing concentrations of ciprofloxacin selected for ciprofloxacin resistance in 26/27 and cefepime nonsusceptibility in 7/27 isolates. Exposure of the isolates to increasing concentrations of cefepime selected for cefepime nonsusceptibility in 20/27 isolates but not for ciprofloxacin resistance.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15917569      PMCID： PMC1140511          DOI： 10.1128/AAC.49.6.2543-2545.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance.

Authors:  A Lee; W Mao; M S Warren; A Mistry; K Hoshino; R Okumura; H Ishida; O Lomovskaya
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

2.  Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756.

Authors:  J C Fung-Tomc; B Minassian; B Kolek; E Huczko; L Aleksunes; T Stickle; T Washo; E Gradelski; L Valera; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

3.  Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa.

Authors:  H Maseda; H Yoneyama; T Nakae
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms.

Authors:  J L Trouillet; A Vuagnat; A Combes; N Kassis; J Chastre; C Gibert
Journal:  Clin Infect Dis       Date:  2002-03-15       Impact factor: 9.079

5.  Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.

Authors:  T Akasaka; M Tanaka; A Yamaguchi; K Sato
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

6.  Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa.

Authors:  O Lomovskaya; A Lee; K Hoshino; H Ishida; A Mistry; M S Warren; E Boyer; S Chamberland; V J Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolates.

Authors:  R Patel; K E Piper; M S Rouse; J M Steckelberg; J R Uhl; P Kohner; M K Hopkins; F R Cockerill; B C Kline
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa.

Authors:  Yang Li; Takehiko Mima; Yukiko Komori; Yuji Morita; Teruo Kuroda; Tohru Mizushima; Tomofusa Tsuchiya
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

9.  Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity.

Authors:  Elisabeth Paramythiotou; Jean-Christophe Lucet; Jean-François Timsit; Dominique Vanjak; Catherine Paugam-Burtz; Jean-Louis Trouillet; Stéphanie Belloc; Najiby Kassis; Andreas Karabinis; Antoine Andremont
Journal:  Clin Infect Dis       Date:  2004-02-17       Impact factor: 9.079
  9 in total
  3 in total

1.  Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patients.

Authors:  C Peña; C Suarez; F Tubau; A Dominguez; M Sora; M Pujol; F Gudiol; J Ariza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-24       Impact factor: 3.267

2.  Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.

Authors:  C Peña; A Guzmán; C Suarez; M A Dominguez; F Tubau; M Pujol; F Gudiol; J Ariza
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

3.  Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs.

Authors:  Josie Hughes; Xi Huo; Lindsey Falk; Amy Hurford; Kunquan Lan; Bryan Coburn; Andrew Morris; Jianhong Wu
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.